Turnberry Hotel

Registration is open for the Antiepileptic Drug and Device (AEDD) Trials XV Conference. The event is sponsored by The Epilepsy Study Consortium in collaboration with the University of Pennsylvania and the Epilepsy Foundation.

May 22-24, 2019

JW Marriott Miami Turnberry
(Formerly Turnberry Isle Miami Hotel)
Aventura (North Miami Beach), Florida

Conference Purpose

The conference focuses on issues surrounding AEDD development, ranging from preclinical discoveries to clinical evaluations. During the course of the meeting, participants will:

  • Obtain an understanding of the processes by which new drugs are discovered, including discussion of new animal models and molecular targets
  • Discuss new translational models in the epilepsy space
  • Discuss new regulatory pathways for epilepsy approval, including orphan indications, and trials for infants with focal epilepsy
  • Discuss new ways to assess seizure frequency in trials, including electronic seizure diaries, wearable devicees, and continuous EEG
  • Discuss with FDA and EMEA representatives new objectives and legislation that have an impact on AED development
  • Discuss improvements for add-on trial designs
  • Summarize discussions from the recent NINDS meeting on antiepileptogenesis
  • Outlining the drugs and devices in preclinical and clinical development for epilepsy

To learn more about conference content, view the draft program.

If you have any questions about the conference, please contact Mary Ann Brodie at The Epilepsy Study Consortium: brodie@epilepsyconsortium.org.

Shark Tank

One exciting feature of the conference is the Epilepsy Foundation Shark Tank Competition, which will be held on Thursday, May 23. This annual competition invites researchers, scientists, entrepreneurs, and more to submit their innovative new ideas in seizure treatment and care for people living with epilepsy. A panel of judges then select a series of finalists who are invited to present their product concepts or candidates at the AEDD Trials Conference.

The winning entry (or entries) will be selected through live voting by conference attendees and a panel of judges (Sharks) representing physicians and scientists, corporate executives, leading industry investors, people with epilepsy, and advocates. The winner(s) will receive international recognition and compete for awards totaling $200,000 to support the development and commercialization of an important new product, technology, or therapeutic concept to help people with epilepsy. Learn about the 2018 Shark Tank winners.

Conference Registration & Fees

  • General Registration on or before February 14, 2019: $600.00
  • Clinical Coordinator/Nurse: $450.00
  • Registration after February 15, 2019: $650.00
  • Onsite registration: $700.00

Register online or download a printable registration form

Hotel Reservations

This year's conference will be held at the:

JW Marriott Miami Turnberry
(Formerly Turnberry Isle Miami Hotel)
19999 West Country Club Drive
Aventura (North Miami Beach), Florida, 33180 USA
Phone: 305.932.6200

The conference rate is $259.00 + tax and resort fee per night. Rooms all have king beds.

This is a special rate for this symposium and only available until April 30, 2019. Please make your reservations early as rooms will be limited. This rate will increase significantly after the deadline.

To reserve your room you may call the Reservations Department at 1-888-539-7894 or make your reservation via Passkey.  Please mention that you are part of the AEDD XV-Antiepileptic Drug and Device Trials.

Travel Grants

The Epilepsy Foundation, the Epilepsy Study Consortium, and the Pediatric Epilepsy Research Foundation have pooled their funds to provide travel grants to the conference for: Epilepsy Fellow/Junior Faculty and Pediatric Epilepsy Fellows. Please see Guidelines to apply.

O<